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ABSTRACTS0544: THE USE OF HUMAN CADAVERS AND VIRTUAL REALITY SIMULA-
TION IN ENDOVASCULAR TRAINING: A QUESTIONNAIRE OF PATIENT
AND PROFESSIONAL OPINION
Stuart Maitland 1, Craig Nesbitt 1, Roger Searle 2, Gerard Stansby 1. 1 Freeman
Hospital, NUT, Newcastle Upon Tyne, UK; 2Newcastle University, NUT,
Newcastle Upon Tyne, UK.
Aim: To establish the opinion of patients and clinicians on the use of vir-
tual reality simulators (VRS) and human cadavers (HC) for endovascular
training.
Methods: Experts in interventional cardiology, radiology and vascular
surgery rated their agreement to statements regarding endovascular
simulation (HC and VRS) through an online questionnaire. Patients' views
on endovascular simulation training were also sought.
Results: 100 professionals completed questionnaires. < 25% were aware
of endovascular HC training, none had ﬁrst hand experience, ﬁve (5.6%)
disagreed with its use. All candidates were aware of VRS, 80.9% had ﬁrst
hand experience. Many expressed interest in HC stating concerns
regarding the realism of VRS. 107 patients (50 non-vascular, 57
vascular*) responded. All patients agreed with HC training. Patients
declared greater conﬁdence in doctors trained on HC versus VRS
(p¼0.000).
Conclusion: These are the ﬁrst recorded opinions of professionals and
patients regarding endovascular simulation training. Endovascular pro-
fessionals question the suitability, appropriateness and feasibility of
endovascular HC training, yet few are wholly satisﬁed with VRS. Patients
appreciate the need for adjunctive simulation training, but harbor mistrust
in computer technology. Enhanced patient education is required to
maintain conﬁdence and trust.
* non-vascular patients have no history of vascular disease
0547: TYPE II ENDOLEAKS: LOW RISK OF RUPTURE AND HIGH RISK OF
TREATMENT FAILURE
David Sidloff, Philip Stather, Eddie Choke, Matt Bown, Robert Sayers.
University of Leicester, Leicester, UK.
Aim: To assess the risk of rupture and determine the beneﬁts of inter-
vention for the treatment of type II endoleaks after endovascular
abdominal aortic aneurysm repair.
Method: A systematic review was performed according to PRISMA
guidelines. Outcome data including incidence, spontaneous resolution,
sac expansion, interventions, success, and complications were recorded.
Results: 32 non-randomised retrospective studies were included, totalling
21,728 patients, 1515 type II endoleaks and 392 interventions. This analysis
reveals type II endoleaks have an incidence of 10% with 32.3% spontane-
ously resolving. 14 ruptures were reported (incidence 0.9%), from which
43% did not have concurrent sac expansion. Analysing interventions, 28%
were unsuccessful. Translumbar embolization had a higher success rate
compared to transarterial embolization (TL81% v TA62.5% P¼0.024) with
fewer persistent endoleaks (TA36% Vs TL19% P¼0.0396). Transarterial
embolizations had a higher associated number of complications (TA10% Vs
TL0% P¼0.0426).
Conclusion: This review has revealed that rupture secondary to an iso-
lated type II endoleak is rare (<1%) and that over a third occur in the
absence of sac expansion. Nearly a third of all interventions for the treat-
ment of type II endoleaks fail, however a translumbar intervention has a
higher success rate with a lower risk of complications.
0555: AN EVALUATION OF OUR EARLY EXPERIENCE OF PERCUTANEOUS
EVAR USING THE PROSTAR XL DEVICE
David Ormesher, Jenna Godfrey, Andrew Schiro, David Murray,
Ferdinand Serracino-Inglott. Department of Vascular and Endovascular
Surgery, Manchester Royal Inﬁrmary, Manchester, UK.
Introduction: There is a trend towards less invasive procedures in all areas
of surgery. It is suggested that the use of percutaneous closure devices for
endovascular procedures that require larger seat sizes may have a positive
impact on patient outcomes.
Methods: A retrospective review of our endovascular logbook was un-
dertaken from which all patients who received a Prostar XL device were
identiﬁed and data collected.
Results: 96 Prostar XL devices were deployed. Mean skin to common
femoral artery (CFA) depth was 31.3mm, all but 5 patients had somedegree of CFA calciﬁcation. The median length of stay was 4 days. 4 pa-
tients went on to develop groin haematomas postoperatively; all of these
were treated conservatively. The Prostar XL cut through the CFA in one
patient and this required repair. 80% of complications were in the ﬁrst 15
cases.
Conclusion: No long-term complications in our series can be attributed to
the percutaneous approach for EVAR. We believe that US-guided puncture
can overcome problems associated with CFA calciﬁcation and that the
depth from skin to CFA has no impact on morbidity. The use of low proﬁle
devices (16F) and operator experience have a positive impact on out-
comes with the Prostar XL device.
0564: TEMPORAL ARTERY BIOPSY e TOO MANY TOO LATE?
Ruth Graham, Lourdusamy Selvam. West Wales General Hospital,
Carmarthen, UK.
Aim: To show Temporal artery biopsy(TAB) rarely inﬂuences patient
management, and that we should use the American College of Rheuma-
tologists (ACR) criteria (Score  3 sensitivity 93.5%, speciﬁcity 91.2%) to
identify which patients require biopsy to diagnose Temporal Arteritis(TA).
Methods: All patients who underwent a TAB at our institution (01/01/
2008-31/12/2011) were identiﬁed using histopathology records. Patient
case notes, histopathology and haematology records were reviewed to
determine the dates of diagnosis, biopsy and corticosteroid therapy and
the initial ACR score.
Results: Of the forty-three patients identiﬁed full data was available on
thirty-seven (13M:24F). The average age was sixty-eight (range 26-79). At
presentation thirty-ﬁve patients were over 50, eighteen had an ESR >50,
twenty-one had temporal tenderness and twenty a localised headache
meaning nineteen (51%) patients had an initial ACR score 3. Prior to bi-
opsy 70% (27) had corticosteroids. The average time from diagnosis to
biopsy was thirty-one days. There were only two positive biopsies (initial
ACR score was 3 in both cases).
Conclusions: TAB has a place in the diagnosis of TA but rarely inﬂuences
patient management. The ACR score should be used to diagnose and
initiate treatment in temporal arteritis. If biopsies are required a fast-track
surgical referral is recommended.
0569: RESULTS OF SIX YEARS OF ENDOVENOUS LASER ABLATION
(EVLA) FOR THE TREATMENT OF RECURRENT VARICOSE VEINS
Andrew McAvoy, Jade Myers, Rhodri Jenkins, Mandy Taylor, Frank Mason.
Southport District General Hospital, Southport, UK.
Varicose vein (VV) recurrence occurs in up to 20% of patients following
open surgery. ‘Re-do' VV surgery is technically challenging and compli-
cation rates approach 40%.
Aim: Our aim was to examine the recurrence and complication rate of
patients undergoing EVLA as a treatment for recurrent VV following pre-
vious surgery at a District General Hospital.
Methods: We included all patients since 2006 who underwent EVLA for
recurrent VV following previous surgery. We examined recurrence rates
and complications following this procedure.
Results: There were 80 EVLA procedures performed for VV recurrence
following previous surgery over the 6 year period. The complication rates
amongst this group of patients is shown below. Wound infection: 0%,
Altered sensation: 6%, Deep Vein Thrombosis: 0%, Phlebitis: 4%, Bleeding:
0%, Overall: 10%.
Post-treatment duplex scanning was performed in 32 patients. 75% of
patients had no residual reﬂux in the treated vein.
Conclusions: The overall complication rate following EVLA as a ‘re-do'
treatment for VV was 10%. Early recurrence rates are 25%. EVLA has a low
complication and recurrence rate when compared to ‘re-do' surgery.
0589: THE ROLE OF PALMAZ STENT-GRAFTS IN EVAR
Claire McManus, Stephen Badger, Julie Reid. Royal Victoria Hospital, Belfast,
Northern Ireland, UK.
Background: Palmaz stenting helps proximal ﬁxation in unfavourable
aneurysm necks. The study aimed to evaluate complications associated
with Palmaz stent-grafts.
Methods: Patients undergoing elective or emergency EVAR repair using a
Palmaz stent-graft between January 2001 and December 2011 were
reviewed. Morphological aneurysm changes were prospectively recorded
